With the exciting proof-of-concept milestones from Phlow, commitments from global regulatory agencies, and breakthroughs from the likes of AbbVie, AstraZeneca, Merck and BMS, over the last 12 months flow chemistry continues to take off at an exponential rate, further evidenced by the significant investments from CDMOs such as Almac, Corden Pharma, Sterling and Cambrex.

Showcasing the steep progress being made whilst addressing the field’s most front-of-mind challenges to enable the full potential of continuous chemistry to come to fruition, the 3rd Annual Commercializing Flow Chemistry Summit is back to bridge the gap between academic and industry innovation as your only meeting bringing both technical and strategic flow chemistry intelligence under one roof in Boston this October.

Uniting 100+ Process Development, Chemistry & Control, PAT, CMC, Continuous Manufacturing and Engineering experts across biopharma, academia, CDMO and fine chemical & API organizations for the first time in person, this is your prime opportunity to turn flow chemistry into industrial applications and implement advanced process control strategies to ensure product quality and meet regulatory expectations.

For practical takeaways across technical chemical engineering, process development, batch to flow transitions, novel chemistries, scale-up, PAT implementation & more, reduce your development cycle and enhance operational efficiency by attending the 3rd CFC Summit 2022!

To know more visit: https://ter.li/pqcevv